Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 4/2013

01-04-2013 | Editorial Comment

Phantom shocks: innocent bystander or complication of implantable cardioverter defibrillator therapy?

Auteur: A. H. Maass

Gepubliceerd in: Netherlands Heart Journal | Uitgave 4/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Excerpt

Implantable cardioverter defibrillators (ICDs) are effective for both primary and secondary prevention of sudden cardiac death. For patients with reduced left ventricular ejection fraction caused by ischaemic or non-ischaemic aetiology, ICDs have received a class I indication in the recent European guidelines [1]. Adherence to the guidelines has led to a steady increase in implantation rates in the Netherlands and Europe over the last years [2]. Health care utilisation even in patients with primary prevention seems to be high [3]. Quality of life (QoL) might not improve after ICD implantation even though there is controversial evidence on this subject. A main determinant of decrease in QoL, at least in a subgroup of patients with ICDs, is the occurrence of adequate and inadequate shocks [4]. The occurrence of phantom shocks is not systematically reported in randomised trials and also largely negated in studies about QoL. …
Literatuur
1.
go back to reference McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRef McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRef
2.
go back to reference van Veldhuisen DJ, Maass AH, Priori SG, et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail. 2009;11:1143–51.CrossRef van Veldhuisen DJ, Maass AH, Priori SG, et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail. 2009;11:1143–51.CrossRef
3.
go back to reference Smith T, van Dessel PF, Theuns DA, et al. Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J. 2011;19:405–11.CrossRef Smith T, van Dessel PF, Theuns DA, et al. Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J. 2011;19:405–11.CrossRef
4.
go back to reference Pedersen SS, Van Den Broek KC, Van Den Berg M, et al. Shock as a determinant of poor patient-centered outcomes in implantable cardioverter defibrillator patients: is there more to it than meets the eye? Pacing Clin Electrophysiol. 2010;33:1430–6.CrossRef Pedersen SS, Van Den Broek KC, Van Den Berg M, et al. Shock as a determinant of poor patient-centered outcomes in implantable cardioverter defibrillator patients: is there more to it than meets the eye? Pacing Clin Electrophysiol. 2010;33:1430–6.CrossRef
5.
go back to reference Kraaier K, Strarrenburg AH, Verheggen RM, et al. Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients. Neth Heart J. 2012. doi:10.1007/s12471-012-0345-z. Epub ahead of print.CrossRef Kraaier K, Strarrenburg AH, Verheggen RM, et al. Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients. Neth Heart J. 2012. doi:10.​1007/​s12471-012-0345-z. Epub ahead of print.CrossRef
6.
go back to reference Buck S, Rienstra M, Maass AH, et al. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. Europace. 2008;10:558–65.CrossRef Buck S, Rienstra M, Maass AH, et al. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. Europace. 2008;10:558–65.CrossRef
7.
go back to reference Jacob S, Panaich SS, Zalawadiya SK, et al. Phantom shocks unmasked: clinical data and proposed mechanism of memory reactivation of past traumatic shocks in patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol. 2012;34:205–13.CrossRef Jacob S, Panaich SS, Zalawadiya SK, et al. Phantom shocks unmasked: clinical data and proposed mechanism of memory reactivation of past traumatic shocks in patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol. 2012;34:205–13.CrossRef
8.
go back to reference de Cock CC, Elders J, van Hemel NM, et al. Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands: an expert consensus report of the Netherlands Society of Cardiology. Neth Heart J. 2012;20:53–65.CrossRef de Cock CC, Elders J, van Hemel NM, et al. Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands: an expert consensus report of the Netherlands Society of Cardiology. Neth Heart J. 2012;20:53–65.CrossRef
Metagegevens
Titel
Phantom shocks: innocent bystander or complication of implantable cardioverter defibrillator therapy?
Auteur
A. H. Maass
Publicatiedatum
01-04-2013
Uitgeverij
Springer Berlin Heidelberg
Gepubliceerd in
Netherlands Heart Journal / Uitgave 4/2013
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-013-0388-9

Andere artikelen Uitgave 4/2013

Netherlands Heart Journal 4/2013 Naar de uitgave